134 related articles for article (PubMed ID: 181194)
1. Reversible resistance to the renal action of parathyroid hormone in man.
Tomlinson S; Hendy GN; Pemberton DM; O'Riordan JL
Clin Sci Mol Med; 1976 Jul; 51(1):59-69. PubMed ID: 181194
[TBL] [Abstract][Full Text] [Related]
2. Impaired responsiveness to the effect of glucagon on plasma adenosine 3':5'-cyclic monophosphate in normal man.
Hendy GN; Tomlinson S; O'Riordan JL
Eur J Clin Invest; 1977 Jun; 7(3):155-60. PubMed ID: 196859
[TBL] [Abstract][Full Text] [Related]
3. Rapid development of renal resistance to low doses of synthetic bovine parathyroid hormone fragment 1-34. Dissociation of urinary cyclic adenosine monophosphate, phosphaturic, and calciuric responses.
Law WM; Heath H
J Clin Invest; 1983 Sep; 72(3):1106-13. PubMed ID: 6309905
[TBL] [Abstract][Full Text] [Related]
4. Reversible resistance to the renal action of parathyroid hormone in human vitamin D deficiency.
Lewin IG; Papapoulos SE; Hendy GN; Tomlinson S; O'Riordan JL
Clin Sci (Lond); 1982 Apr; 62(4):381-7. PubMed ID: 6279352
[TBL] [Abstract][Full Text] [Related]
5. Effect of bovine parathyroid hormone 1-34 fragment on renal production and excretion of adenosine 3', 5' monophosphate in man.
Czekalski S; Loreau N; Paillard F; Ardaillou R; Fillastre JP; Mallet E
Eur J Clin Invest; 1974 Apr; 4(2):85-92. PubMed ID: 4832719
[TBL] [Abstract][Full Text] [Related]
6. Urinary cyclic AMP excretion in birds: dependence on parathyroid hormone activity.
Pines M; Polin D; Hurwitz S
Gen Comp Endocrinol; 1983 Jan; 49(1):90-6. PubMed ID: 6298061
[TBL] [Abstract][Full Text] [Related]
7. Renal 1,25-dihydroxyvitamin D, phosphaturic, and cyclic-AMP responses to intravenous synthetic human parathyroid hormone-(1-34) administration in normal subjects.
Slovik DM; Daly MA; Potts JT; Neer RM
Clin Endocrinol (Oxf); 1984 Apr; 20(4):369-75. PubMed ID: 6325049
[TBL] [Abstract][Full Text] [Related]
8. Effect of renal function on renal responsiveness to parathyroid hormone in primary hyperparathyroidism and chronic renal failure.
Lewin IG; Hendy GN; Papapoulos SE; Tomlinson S; O'Riordan JL
Eur J Clin Invest; 1985 Feb; 15(1):38-44. PubMed ID: 2985400
[TBL] [Abstract][Full Text] [Related]
9. Skeletal resistance to endogenous parathyroid hormone in pateints with early renal failure. A possible cause for secondary hyperparathyroidism.
Llach F; Massry SG; Singer FR; Kurokawa K; Kaye JH; Coburn JW
J Clin Endocrinol Metab; 1975 Aug; 41(2):339-45. PubMed ID: 169280
[TBL] [Abstract][Full Text] [Related]
10. Renal adenylate cyclase and the interrelationship between parathyroid hormone and vitamin D in the regulation of urinary phosphate and adenosine cyclic 3',5'-monophosphate excretion.
Forte LR; Nickols GA; Anast CS
J Clin Invest; 1976 Mar; 57(3):559-68. PubMed ID: 175088
[TBL] [Abstract][Full Text] [Related]
11. Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man.
Kaminsky NI; Broadus AE; Hardman JG; Jones DJ; Ball JH; Sutherland EW; Liddle GW
J Clin Invest; 1970 Dec; 49(12):2387-95. PubMed ID: 5480862
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of resistance to the phosphaturic effect of the parathyroid hormone in the hamster.
Knox FG; Preiss J; Kim JK; Dousa TP
J Clin Invest; 1977 Apr; 59(4):675-83. PubMed ID: 14974
[TBL] [Abstract][Full Text] [Related]
13. Renal cyclic adenosine monophosphate: an accurate index of parathyroid function.
Drezner MK; Neelon FA; Curtis HB; Lebovitz HE
Metabolism; 1976 Oct; 25(10):1103-12. PubMed ID: 184364
[TBL] [Abstract][Full Text] [Related]
14. Effect of parathyroid hormone on plasma prolactin in man.
Isaac R; Merceron RE; Caillens G; Raymond JP; Ardaillou R
J Clin Endocrinol Metab; 1978 Jul; 47(1):18-23. PubMed ID: 233660
[TBL] [Abstract][Full Text] [Related]
15. [The diagnostic value of the determination of cyclic 3',5'-adenosine monophosphate (cAMP) in urine].
Gennari C; Galli M; Montagnani M; D'Amore I
Quad Sclavo Diagn; 1976 Mar; 12(1):15-38. PubMed ID: 190633
[TBL] [Abstract][Full Text] [Related]
16. Effects of the intravenous administration of calcium on nephrogenous cyclic AMP: use as a parathyroid suppression test.
Broadus AE; Deftos LJ; Bartter FC
J Clin Endocrinol Metab; 1978 Mar; 46(3):477-87. PubMed ID: 221521
[TBL] [Abstract][Full Text] [Related]
17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone does not increase nephrogenous cyclic AMP excretion by the dog.
Fox J; Heath H
Endocrinology; 1980 Dec; 107(6):2124-5. PubMed ID: 6253291
[TBL] [Abstract][Full Text] [Related]
19. A multivariate factor analysis of the high plasma concentration of cyclic AMP in patients with chronic renal failure.
Marumo F; Sakai T; Shirataka M
Int J Artif Organs; 1980 Jan; 3(1):18-22. PubMed ID: 6243611
[TBL] [Abstract][Full Text] [Related]
20. Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency.
Rude RK; Oldham SB; Singer FR
Clin Endocrinol (Oxf); 1976 May; 5(3):209-24. PubMed ID: 182417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
